A select number of academic programs earn the designation as a Center of Excellence by the Louisiana Board of Regents and must demonstrate statewide leadership in their area of focus and a commitment to building on their respective strengths by advancing knowledge and skills to create better opportunities for improving the quality of life of Louisiana residents. Designated centers share being a hallmark of the institution with a strong performance record, concentration in a clearly defined area relevant to the state’s needs, a range of academic, training and research opportunities, and engagement with the greater community to address current issues. LSU Health Shreveport is home to four designated Centers of Research Excellence.

Feist-Weiller Cancer Center

FWCC icon

The Feist-Weiller Cancer Center team is committed to bringing life-saving discoveries about cancer to all of Louisiana and beyond. Collaboration between cancer researchers and treating physicians fosters a more comprehensive understanding of cancer.

Learn More

Center of Excellence for Arthritis and Rheumatology

CEAR icon

The Center engages in a multidisciplinary clinical, research and education mission to provide patients with cutting-edge care, advance the science of inflammatory and immunology diseases and to educate physicians.

Learn More

Center for Cardiovascular Diseases and Sciences

CCDS icon

The Center's mission is to advance the understanding of cardiovascular disease and translational research while developing future generations of basic and clinical science investigators.

Learn More

Center for Emerging Viral Threats

cevt icon

The Center intersects critical public health needs with timely delivery of clinical and vaccine trials, testing, key SARS-CoV2 and other pathogen clinical diagnosis, community education, and training scientists, physicians and health work force.

Learn More


Center for Brain Health

cbh icon

The Center for Brain Health expands neuroscience-related education, provides comprehensive care for brain disorders, and attracts young specialists and pioneering clinical trials to North Louisiana, and competes for large scale research funding.

Learn More

Louisiana Addiction Research Center

larc icon

LARC is committed to increasing knowledge and advancing research related to Substance Use Disorders to create a better quality of life for the citizens of our area.


Learn More

Center of Academic Excellence for Patient Centered Rehabilitation

The School of Allied Health Professions' Center (CAE-PaCeR) will establish an infrastructure to bring the relevant academic, research, and clinical programs of the School into alignment for clinical learning, innovation, and collaboration.

Learn More

Centers of Biomedical Research Excellence

In addition to the six Louisiana Board of Regents and LSU Board of Supervisors approved Centers, LSU Health Shreveport has two National Institutes of Health (NIH) Centers of Biomedical Research Excellence (COBRE). The Centers of Biomedical Research Excellence (COBRE) awards support the establishment and development of innovative, state-of-the-art biomedical and behavioral research centers at institutions in IDeA-eligible states through awards for three sequential five-year phases.

Center for Applied Immunology and Pathological Processes

The Center for Applied Immunology and Pathological Processes, directed by Dr. Andrew Yurochko, was established In 2021, supported by a five year, $10.5 million grant from the NIH.

 Learn More

Center for Redox Biology and Cardiovascular Disease

The Center for Redox Biology and Cardiovascular Disease, directed by Dr. Chris Kevil, was established in 2018 and is supported by a five-year, $10.5 million NIH COBRE grant.

Learn More

Our Centers are actively engaged in educating the community,
training future scientists and advancing research through active collaborations.


Latest Research Centers News

Dr. Gary Burton instructs staff at Feist-Weiller Cancer Center

Feist-Weiller Cancer Center, a Center of Excellence in Cancer Research, Treatment and Education at LSUHS and Loxo@Lilly, the oncology unit of Eli Lilly and Company, recently launched a new research collaboration that will provide next-generation sequencing (NGS) access to underserved cancer patients in the northern Louisiana region.

Read More about LSUHS, Loxo@Lilly Partner to Study Impact of Next-Generation Sequencing on Cancer Treatment Decisions and Patient Outcomes
three women in a lab

The Center for Emerging Viral Threats at LSUHS recently sequenced the first instances in Louisiana of the XBB.1.16 and XBB.1.9.1 variants. "Detecting these very recently emerging variants demonstrates the robustness of our efforts,” said Krista Queen, PhD, Director of Viral Genomics and Surveillance.

Read More about CEVT Continues to Expand Viral Sequencing Efforts, Sequences Two Omicron Subvariants Becoming More Prevalent in the U.S.
Photo of Center of Brain Health team viewing screens of brain for evaluation

Our Centers

We Teach. We Heal. We Discover.